偉思醫療(688580.SH):已構建了覆蓋人體上下肢、全週期康復評估與訓練的運動康復機器人產品矩陣
格隆匯6月6日丨偉思醫療(688580.SH)在投資者互動平台表示,公司已構建了覆蓋人體上下肢、全週期康復評估與訓練的運動康復機器人產品矩陣。公司康復機器人產品與磁刺激、電刺激、衝擊波等其他康復理療類產品深度融合,形成了涵蓋神經康復、運動康復、重症康復、老年慢性病康復等多種康復亞專科的精品解決方案,精準滿足康復改善型市場需求。未來,公司康復機器人業務將持續致力於為臨牀提供智能化、標準化、效果可評估的應用解決方案,提升康復效率和效果。在確保產品品質的前提下,公司將持續推進產品迭代升級與成本優化,進一步鞏固並提升在康復市場中高端領域的核心競爭力。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.